606 results on '"Cirioni, Oscar"'
Search Results
52. Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting
53. Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates
54. IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus
55. Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide
56. Experimental study on the efficacy of combination of α-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides
57. Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection
58. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection
59. Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation
60. Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know
61. Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus
62. In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-β-d-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci
63. Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin-resistant Staphylococcus aureus
64. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection
65. Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis
66. whISOBAXTM Inhibits Bacterial Pathogenesis and Enhances the Effect of Antibiotics
67. Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties
68. New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection
69. Potential application of berberine in the treatment of Escherichia coli sepsis
70. Witch Hazel Significantly Improves the Efficacy of Commercially Available Teat Dips
71. Animal Models Commonly Used to Study Quorum-Sensing Inhibitors
72. S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis
73. OpuC - an ABC transporter that is associated with Staphylococcus aureus pathogenesis
74. Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis
75. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients
76. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection
77. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis
78. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock
79. Protective effects of the combination of α-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection
80. In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum
81. Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosaisolates in a university hospital in central Italy
82. Pretreatment With the Protegrin IB-367 Affects Gram-Positive Biofilm and Enhances the Therapeutic Efficacy of Linezolid in Animal Models of Central Venous Catheter Infection
83. In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH2 alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans
84. The lipopeptides Pal–Lys–Lys–NH2 and Pal–Lys–Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection
85. In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi
86. In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics
87. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci
88. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models
89. Potential application of berberine in the treatment of Escherichia coli sepsis.
90. Cathelicidin Peptide Sheep Myeloid Antimicrobial Peptide-29 Prevents Endotoxin-induced Mortality in Rat Models of Septic Shock
91. Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock
92. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides
93. Comparative activities of cecropin A, melittin, and cecropin A–melittin peptide CA(1–7)M(2–9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii
94. In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides
95. Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection
96. Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock
97. Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture
98. Comparative activities of cecropin A, melittin, and cecropin A–melittin peptide CA(1–7)M(2–9)NH 2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii
99. Dalbavancin and wound healing: new evidences/insights in a mouse model of skin infection
100. Cationic Peptides Combined with Betalactams Reduce Mortality from Peritonitis in Experimental Rat Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.